Evaluates anticancer properties of binuclear organoselenium compounds against lung and breast cancer, suggesting therapeutic potential.
Herein, we report the synthesis of three new binuclear Organoselenium compounds, dicyclopentyl-1H-imidazole-hexyl-2-selenone (MC1), dibenzyl-1H-imidazole-hexyl-2-selenone (MC2), and dipentyl-1H-imidazole-hexyl-2-selenone (MC3), by deprotonation of corresponding imidazolium salts (ML1-ML3) via a green synthetic approach....
No takes yet. Share an insight, caveat, or question.
Abbas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: